Maryam Payne[email protected]Alzheimer'sUrine biomarker may reveal early-stage Alzheimer’s disease, study showsA urine-based test for early Alzheimer’s detection would be inexpensive, noninvasive, widely accessible, and considerably easier to deploy in routine screening than current methods.November 30, 2022DiabetesWidespread HbA1c screening enables earlier type 2 diabetes diagnosis in U.K. studyHbA1c screening in adults between 40 and 70 years of age can reduce the time to diabetes diagnosis by a median of 2.2 years compared with routine clinical care, the authors found.November 22, 2022CancerLancet report on gaps in European cancer research calls for prioritization of prevention, early diagnosisA report published in Lancet Oncology found that an estimated 100 million cancer screening tests were missed during the first year of the COVID-19 pandemic.November 16, 2022Alzheimer'sAlzheimer’s study compares blood-based biomarkers, other detection technologiesThe Global Alzheimer’s Platform Foundation technology study, with more than 1,000 participants, focuses on access and diversity.November 15, 2022COVID-19Study calls attention to disparities in COVID-19 test and treatment accessResearchers examined disparities in access to COVID-19 antiviral treatments for minority and high-risk populations, especially those in rural areas.November 10, 2022Point-of-Care TestingBMJ investigation: Private testing causing concerns and additional work for NHSAmbiguity about test results, lack of counseling, and blanket recommendations to see one’s doctor following abnormal test results put further strain on providers in the already-overtaxed NHS, the BMJ article asserts.October 27, 2022Breast CancerMulticenter study highlights deficiencies in invasive lobular carcinoma assessmentThe researchers emphasized that the study results, and the difficulties inherent in detecting ILC on mammograms, demonstrate the need for molecular tests specifically designed for ILC.October 17, 2022Small Cell Lung CancerNew gene target discovered for aggressive small-cell lung cancer subtypeThe research team plans to develop a drug to disrupt the functioning of the POU2AF2 gene. Furthermore, because of POU2AF2’s specificity to the subtype, it may serve as a biomarker, leading to earlier diagnosis.October 10, 2022COVID-19U.K. study: Blood test may predict long-COVID riskA U.K. study led by researchers at University College London (UCL) shows that a blood test performed during the initial infection period may predict who is most likely to develop long COVID.September 29, 2022Previous PagePage 2 of 2Top StoriesValidationImmunovia announces positive results for next-gen pancreatic cancer testDiagnostics company Immunovia announced positive results for the newest generation of its pancreatic cancer test from a model-development study, announcing that the test achieved both its primary and secondary endpoints.CollaborationVertex to pay $25M upfront to scale cell manufacturing technologyFinancial ResultsBristol Myers Squibb to reduce workforce in restructuring planLawsuitU.K. Patents Court rules Bio-Techne patents invalid in infringement lawsuitSponsor ContentVisit our Molecular Diagnostics Community